Speaker illustration

Doctor Leon Dinshaw

University Heart Center Hamburg, Hamburg (Germany)

Temporal trend of clinical events in patients with atrial fibrillation on edoxaban therapy: results from the non-interventional global ETNA-AF program

Event: ESC Congress 2021 - The Digital Experience

Topic: Anticoagulants

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

Annualized clinical event rates during two-year follow-up are low in 27,617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program

Event: EHRA 2021

Topic: Oral Anticoagulation

Session: Prevention of stroke in atrial fibrillation

Thumbnail

Long-term outcome of non-pharmacologial treatment of atrial fibrillation in hypertrophic cardiomyopathy: a large single-centre experience

Event: ESC CONGRESS 2019

Topic: Rhythm Control, Hybrid Therapy

Session: Epidemiology of atrial fibrillation

Thumbnail

Long-term outcome of ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

Event: EHRA 2018

Topic: Rhythm Control, Hybrid Therapy

Session: Atrial fibrillation ablation - Mechanisms and outcomes

Thumbnail

Elevated risk of ventricular tachyarrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy and a prolonged T-peak to T-end interval

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: ECG and arrhythmia analysis

Session: ECG and eCardiology

Thumbnail

This platform is supported by

logo Novo Nordisk